These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7835641)

  • 1. Comparative analysis of vasodilating mechanisms of Ki1769, Ki3315 and KRN2391, pyridinecarboximidamide derivatives, in porcine isolated coronary artery.
    Yokoyama T; Okada Y; Jinno Y; Izumi H; Izawa T; Ogawa N
    Gen Pharmacol; 1994 Sep; 25(5):941-5. PubMed ID: 7835641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasorelaxant action of Ki1769, a new pyridinecarboximidamide, in isolated porcine coronary artery.
    Okada Y; Yokoyama T; Jinno Y; Kashiwabara T; Izawa T; Fukushima H; Ogawa N
    Eur J Pharmacol; 1993 Sep; 241(2-3):177-81. PubMed ID: 8243553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo K channel-opening effects of Ki3315, a metabolite of the novel vasodilator KRN2391.
    Tanaka Y; Okada Y; Yokoyama T; Nakajima T; Izawa T; Fukushima H; Ogawa N
    Arch Int Pharmacodyn Ther; 1993; 326():62-71. PubMed ID: 8185414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of cyclic GMP formation to KRN2391-induced relaxation in coronary artery of the pig.
    Jinno Y; Kasai H; Ohta H; Nishikori K; Fukushima H; Ogawa N
    Br J Pharmacol; 1992 Aug; 106(4):906-9. PubMed ID: 1327392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological analysis of the inhibitory effects of KRN2391 on endothelin-1-induced contraction in isolated large coronary artery of the pig.
    Harada K; Miwa A; Yokoyama T; Izawa T; Ogawa N; Jinno Y
    Gen Pharmacol; 1994 Sep; 25(5):935-9. PubMed ID: 7835640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasorelaxant mechanism of KRN2391 and nicorandil in porcine coronary arteries of different sizes.
    Miwa A; Kaneta S; Motoki K; Jinno Y; Kasai H; Okada Y; Fukushima H; Ogawa N
    Br J Pharmacol; 1993 Jul; 109(3):632-6. PubMed ID: 8358563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilating properties of KRN2391: structural basis of a new pyridine-type potassium channel opener with a nitrate moiety.
    Ishibashi T; Hamaguchi M; Imai S
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):94-101. PubMed ID: 1357559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of the nitrate-like and K channel opening actions of KRN2391 in canine coronary arterial smooth muscle.
    Okada Y; Yanagisawa T; Taira N
    Br J Pharmacol; 1991 Dec; 104(4):829-38. PubMed ID: 1810597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of action of KRN2391 in canine coronary vascular bed.
    Fukata Y; Kaneta S; Okada Y; Yokoyama T; Jinno Y; Fukushima H; Ogawa N
    Jpn J Pharmacol; 1993 Nov; 63(3):305-11. PubMed ID: 8107323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissimilarity in the mechanisms of action of KRN2391, nicorandil and cromakalim in canine renal artery.
    Kasai H; Fukata Y; Harada K; Fukushima H; Ogawa N
    J Pharm Pharmacol; 1993 Mar; 45(3):222-4. PubMed ID: 8097782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of KRN2391 and other coronary dilators on porcine isolated coronary arteries of different sizes.
    Kasai H; Jinno Y; Kaneta S; Fukata Y; Fukushima H; Ogawa N
    J Pharm Pharmacol; 1993 Jun; 45(6):573-5. PubMed ID: 8103109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasospasmolytic effect of KRN2391 on 3,4-diaminopyridine-induced rhythmic contraction of porcine coronary artery.
    Miwa A; Takeuchi A; Fukata Y; Izumi H; Izawa T; Ogawa N
    Gen Pharmacol; 1994 Oct; 25(6):1171-8. PubMed ID: 7875541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of KRN2391, a novel vasodilator, on pancreatic exocrine secretion in anesthetized dogs.
    Iwatsuki K; Horiuchi A; Ren LM; Chiba S
    Eur J Pharmacol; 1993 Nov; 249(1):19-24. PubMed ID: 8282016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Ki1769, a novel vasodilator, in isolated rat aorta.
    Kashiwabara T; Nakajima T; Kasai H; Nakajima S; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):175-83. PubMed ID: 7979826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K+ channel-opening action and KRN2391-induced reduction of Ca2+ sensitivity of arterial smooth muscle.
    Okada Y; Yanagisawa T; Yamagishi T; Taira N
    Arch Int Pharmacodyn Ther; 1993; 326():33-51. PubMed ID: 8185411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationship of a novel K+ channel opener, KRN4884, and related compounds in porcine coronary artery.
    Izumi H; Tanaka Y; Okada Y; Ogawa N; Izawa T
    Gen Pharmacol; 1996 Sep; 27(6):985-9. PubMed ID: 8909979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KRN2391: dual action on rat pulmonary artery and no loss of potency in pulmonary hypertension.
    Wanstall JC; Gambino A; Thomas BJ
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):288-94. PubMed ID: 10779127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of K+ channel openers, KRN2391 and Ki1769, and nitroglycerin on the urinary tract of rats in vivo.
    Kontani H; Jinkawa M; Shiraoya C; Nagashima A
    Jpn J Pharmacol; 1999 Jun; 80(2):143-53. PubMed ID: 10440533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasodilator action in the nitroxylated cyanoamidine derivative, KRN2391, in rabbit basilar artery.
    Ryman T; Petersson J; Högestätt ED
    Pharmacol Toxicol; 1999 Aug; 85(2):80-4. PubMed ID: 10488689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential vasodilator properties of KRN2391, cromakalim, nitroglycerin and nifedipine in rabbit isolated femoral artery and vein.
    Kashiwabara T; Ogawa N; Izawa T; Fukushima H
    Br J Pharmacol; 1994 Jan; 111(1):278-82. PubMed ID: 8012706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.